Molly Shoichet is a University Professor at the University of Toronto, holding primary appointments in the Department of Chemical Engineering and Applied Chemistry and cross-appointments in the Department of Chemistry. Her research focuses on regenerative medicine, tissue engineering, and drug delivery, with a particular emphasis on developing biomaterials for neural and ocular therapies. She leads the Shoichet Lab, known for cross-disciplinary approaches combining engineering, chemistry, and biology to address unsolved medical challenges. Her scientific contributions include the design of hydrogels for cell and drug delivery, lipid nanoparticles for RNA therapeutics, and enzyme-stabilization strategies for stroke recovery. She holds the inaugural Pamela and Paul Austin Chair in Precision and Regenerative Medicine, reflecting her leadership in the field. Recent research highlights include: Developing novel drug delivery systems for glaucoma treatment Advancing inhalation-based RNA delivery platforms Engineering hydrogels for sustained release of therapeutic proteins Her work has led to over 300 citations and multiple startups, such as AmacaThera, translating her innovations into clinical solutions. She advises graduate students like Dr. Lia Huo and Olivia Li, and her lab collaborates with global institutions including the Natural Sciences and Engineering Research Council (NSERC) and the Canadian Institutes of Health Research (CIHR).








